These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23647748)

  • 1. Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity.
    Meijneke TR; Petit SF; Wentzler D; Hoogeman M; Nuyttens JJ
    Radiother Oncol; 2013 Jun; 107(3):423-7. PubMed ID: 23647748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
    Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
    J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
    Karlsson K; Nyman J; Baumann P; Wersäll P; Drugge N; Gagliardi G; Johansson KA; Persson JO; Rutkowska E; Tullgren O; Lax I
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):590-5. PubMed ID: 24074933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 doses.
    Schröder C; Stiefel I; Tanadini-Lang S; Pytko I; Vu E; Guckenberger M; Andratschke N
    Radiother Oncol; 2020 Nov; 152():56-62. PubMed ID: 32717358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung reirradiation with stereotactic body radiotherapy.
    Maranzano E; Draghini L; Anselmo P; Casale M; Arcidiacono F; Chirico L; Italiani M; Trippa F
    J Radiosurg SBRT; 2016; 4(1):61-68. PubMed ID: 29296427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
    Nuyttens JJ; van der Voort van Zyp NC; Praag J; Aluwini S; van Klaveren RJ; Verhoef C; Pattynama PM; Hoogeman MS
    Radiother Oncol; 2012 Mar; 102(3):383-7. PubMed ID: 22265734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.
    Duijm M; Tekatli H; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Senan S; Nuyttens JJ
    Radiother Oncol; 2018 May; 127(2):233-238. PubMed ID: 29478763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
    Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
    Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy.
    Schipani S; Wen W; Jin JY; Kim JK; Ryu S
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e571-6. PubMed ID: 22975607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
    Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
    Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy.
    Peulen H; Karlsson K; Lindberg K; Tullgren O; Baumann P; Lax I; Lewensohn R; Wersäll P
    Radiother Oncol; 2011 Nov; 101(2):260-6. PubMed ID: 22056534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.